Genmab (United States)

Genmab (United States)

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Genmab (United States), United States, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

58%


Total
Publications

460


Total Open
Publications

266


Total
Citations

15K


Open Access
Percentage

58%


Total
Publications

460


Total Open
Publications

266


Total
Citations

15K

Wikipedia

Website

download

Breakdown

32% 20% 6% 42%

Publisher Open

32%

Both

20%

Other Platform Open

6%

Closed

42%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

63

Hybrid 27%

65

No Guarantees 46%

109

Other Platform Open

Domain 72%

86

Institution 26%

31

Preprint 14%

17

Other Internet 13%

15

Public 6%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
88
Europe PMC
Domain
28
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
13
University College London - UCL Discovery
Institution
8
DOI
Other Internet
7
bioRxiv
Preprint
6
Figshare
Public
5
Erasmus University Rotterdam - EUR Research Repository
Institution
5
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
5
Cardiff University - ORCA Online Research @Cardiff
Institution
5
1 / 5

Data updated 13 February 2025

Share

Share

Share